We are live on
!
Find out more
SFM
Systematic Financial Management Portfolio holdings
AUM
$4.36B
1-Year Est. Return
40.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.16%
1 Year Est. Return
+40.56%
3 Year Est. Return
+82.4%
5 Year Est. Return
+101.84%
10 Year Est. Return
+456.43%
AUM
$2.57B
AUM Growth
-$351M
(-12%)
Cap. Flow
-$406M
Cap. Flow
% of AUM
-15.78%
Top 10 Holdings %
Top 10 Hldgs %
11.78%
Holding
699
New
61
Increased
76
Reduced
452
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$7.57M |
| 2 |
AngioDynamics
ANGO
|
+$6.62M |
| 3 |
Acuity Brands
AYI
|
+$6.57M |
| 4 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.43M |
| 5 |
Visteon
VC
|
+$3.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entergy
ETR
|
+$13.9M |
| 2 |
Watts Water Technologies
WTS
|
+$6.27M |
| 3 |
Citizens Financial Group
CFG
|
+$5.78M |
| 4 |
CHCT
Community Healthcare Trust
CHCT
|
+$5.69M |
| 5 |
Intel
INTC
|
+$5.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.39% |
| 2 | Industrials | 16.76% |
| 3 | Technology | 12.37% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Real Estate | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Sony
SONY
$123B
| $1.1M | 0.04% |
105,000
+22,575
| +27% | +$222K |
|
252
Myriad Genetics
MYGN
$530M
| $1.07M | 0.04% |
38,385
-1,395
| -4% | -$39.4K |
|
253
Stratasys
SSYS
$697M
| $1.07M | 0.04% |
36,295
-9,525
| -21% | -$226K |
|
254
Equitable Holdings
EQH
$13.1B
| $1.06M | 0.04% |
+50,943
| New | +$1.1M |
|
255
ANI Pharmaceuticals
ANIP
$1.77B
| $1.06M | 0.04% |
+12,895
| New | +$917K |
|
|
MGLN
256
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.05M | 0.04% |
14,170
-5,535
| -28% | -$372K |
|
257
Biogen
BIIB
$29.9B
| $1.05M | 0.04% |
4,491
-549
| -11% | -$127K |
|
258
Ericsson
ERIC
$30.7B
| $1.05M | 0.04% |
110,565
-21,068
| -16% | -$204K |
|
259
ArcBest
ARCB
$3.44B
| $1.04M | 0.04% |
37,022
-7,680
| -17% | -$223K |
|
260
AAR Corp
AIR
$5.15B
| $1.04M | 0.04% |
+28,245
| New | +$934K |
|
261
Hancock Whitney
HWC
$6.13B
| $1.04M | 0.04% |
25,915
+18,535
| +251% | +$764K |
|
262
News Corp Class A
NWSA
$14.5B
| $1.04M | 0.04% |
76,805
-19,640
| -20% | -$240K |
|
263
CACI
CACI
$10.8B
| $1.03M | 0.04% |
5,050
-3,685
| -42% | -$729K |
|
264
Medpace
MEDP
$16.8B
| $1.03M | 0.04% |
15,790
-6,955
| -31% | -$401K |
|
265
Eli Lilly
LLY
$1.07T
| $1.03M | 0.04% |
9,295
-1,770
| -16% | -$208K |
|
266
Aecom
ACM
$9.07B
| $1.03M | 0.04% |
27,130
-13,920
| -34% | -$463K |
|
267
AGCO
AGCO
$8.78B
| $1.03M | 0.04% |
13,230
-6,785
| -34% | -$484K |
|
268
Evertec
EVTC
$1.83B
| $1.02M | 0.04% |
31,170
-12,985
| -29% | -$382K |
|
269
Edison International
EIX
$30.7B
| $1.01M | 0.04% |
15,042
-38,289
| -72% | -$2.38M |
|
|
MDRX
270
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.01M | 0.04% |
86,960
-24,555
| -22% | -$250K |
|
271
Badger Meter
BMI
$3.66B
| $1.01M | 0.04% |
+16,925
| New | +$938K |
|
|
PRSP
272
DELISTED
Perspecta Inc. Common Stock
PRSP
| $1.01M | 0.04% |
43,094
-109,375
| -72% | -$2.46M |
|
273
Haemonetics
HAE
$3.58B
| $1.01M | 0.04% |
8,360
-6,710
| -45% | -$660K |
|
|
VRS
274
DELISTED
Verso Corporation
VRS
| $1.01M | 0.04% |
52,825
+900
| +2% | +$18.2K |
|
275
Insight Enterprises
NSIT
$3.55B
| $1M | 0.04% |
17,235
-6,310
| -27% | -$352K |
|
Similar funds
EC
EQF
B
NHC
NEI
FIS
CFO
Systematic Financial Management's Q2 2019 Portfolio in Review
As of Q2 2019, Systematic Financial Management held 699 positions worth $2.57B, down 12% from $2.92B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Systematic Financial Management withdrew a net $406M in Q2 2019, closing 82 positions and reducing 452 holdings. Its most notable exit was Gen Digital, an estimated $5.29M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
Against the trend, Systematic Financial Management opened a new position in Acuity Brands worth $6.59M.
- Systematic Financial Management's largest Q2 2019 buy was Acuity Brands: 47,755 shares worth $6.59M.
- Systematic Financial Management added most to Jazz Pharmaceuticals in Q2 2019, an estimated $7.57M increase.
- Systematic Financial Management's biggest Q2 2019 reduction was Entergy, cutting an estimated $13.9M.
- Systematic Financial Management fully exited Gen Digital in Q2 2019, selling an estimated $5.29M.
- Systematic Financial Management's ten largest holdings make up 12% of its $2.57B portfolio in Q2 2019.
- Systematic Financial Management opened 61 new positions and closed 82 in Q2 2019.
- Systematic Financial Management's portfolio value fell 12% quarter-over-quarter to $2.57B.
Based on Systematic Financial Management's 13F filing for Q2 2019, filed 26 Jul 2019.